Healthcare -
Biotechnology - NASDAQ - US
$ 0.023
-0.87 %
$ 914 K
Market Cap
-0.02
P/E
VIRX - CAPITAL EXPENDITURES
Capital Expenditures VIRX - Viracta Therapeutics, Inc.
-138 K
LAST VALUE
81.98%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR